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Abstract
Background: Cervical Disc Arthroplasty (CDA) seems to be an alternative to Anterior Cervical Decompression and
Fusion (ACDF) and was developed to minimize the risk of Adjacent Segment Disease (ASD). The ROTAIO Cervical
Disc Prosthesis represents a new unconstrained implant with a variable centre of rotation which should enable
physiological facet-guided movement. The aim of this current study was to evaluate the clinical outcomes after
arthroplasty using ROTAIO Cervical Disc Prosthesis.
Method: Twenty-seven female and 18 male patients (n = 45) with a mean age of 43.7 ± 7.8 years were prospectively
followed up for a maximum of 24 month. Clinical outcomes were assessed by Neck Disability Index (NDI), visual
analogue scale (VAS) scores for neck and arm pain, patients´ overall satisfaction and the usage of analgesics.
Additionally, radiographic information including ROM of the functional spinal unit (FSU) and signs of adjacent segment
disease were recorded.
Results: NDI and VAS scores showed significant improvement 6 months after surgery and at last follow-up (p < 0.001).
Concerning overall satisfaction 95.7 % of the patients showed good to excellent results at the last visit and a significant
reduction of analgesic usage was observed (p < 0.001). Radiographic measurements showed a mean increase of ROM
up to 8.40° in the treated FSU at last follow-up (p < 0.001). No signs of anterior migration or dislocation of the
prosthesis and no subsidence was recorded radiographically. There were no major complications and a low rate of
secondary procedures (2.2 %).
Conclusion: In the 24-months follow-up the ROTAIO Cervical Disc Prosthesis provided excellent clinical and
radiographical results and seems to be safe and effective for the treatment of symptomatic single-level degenerative
disc disease.
Keywords: Cervical disc replacement, Cervical disc arthroplasty, Range of motion, Spinal instrumentation
Background
Cervical spondylosis and degenerative disc disease may
result in compression of one or more nerve roots and/or
the spinal cord. If non-operative treatment fails, anterior
cervical discectomy and fusion (ACDF) is a common
treatment for cervical radiculopathy and myelopathy [1].
The procedure shows high patient satisfaction scores and
a 95 % arthrodesis rate [2, 3]. Nevertheless the technique
causes a loss of segmental motion and a possible need for
reoperation because of pseudoarthrosis or adjacent seg-
ment degeneration (ASD). In recent years, cervical disc re-
placement (CDR) has become popular as an alternative to
ACDF. Its theoretical and observed advantages include a
more physiologic distribution of range of motion (ROM),
reduced adjacent level stresses and a lowered rate of ASD.
Currently, there are many commercially available artificial
discs with different biomechanical properties [3–7].
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This study reports the first results of a prospective,
two-centre observational clinical trial on a newly devel-
oped artificial disc replacement device. There are cur-
rently no long term reports about the ROTAIO
Cervical Disc Prosthesis (SIGNUS Medizintechnik
GmbH, Alzenau, Germany). The study objective was to
evaluate the clinical and radiological outcome after a
maximum follow up of two years and to compare the
results to available data of other artificial disc devices.
Methods
The observation was institutional review board approved
(Ethics Commission, Medical University Innsbruck –
Austria). All patients at the two centres who met the in-
clusion/exclusion criteria provided written informed
consent and were included in the trial. Patient selection
was based on the following inclusion and exclusion cri-
teria. Inclusion criteria: (1) 18 to 65 years of age, (2) a
single cervical disc disease between the level C3 and C7,
(3) failed conservative treatment of at least 6 weeks or in
case of progressive nerve root or spinal cord compres-
sion and (4) a minimum Neck Disability Index (NDI) of
15 points (30 %). Exclusion criteria: (1) cervical instabil-
ity defined by translation on flexion–extension radio-
graphs compared to the adjacent level, (2) non-mobility
of the level, (3) fused adjacent levels, (4) neck pain as
the solitary symptom, (5) prior surgery at target level, (6)
metabolic bone disease or endocrine disorders, (7) preg-
nancy, (8) traumatic injury of spine, (9) HIV, metastatic
cancer, presence of infection and (10) allergy to materials
used in the device.
Demographic data
From January 2011 to December 2012, CDRs using the
ROTAIO Cervical Disc Prosthesis were performed in 45
patients. All patients were successfully included, 28 pa-
tients had their last follow-up 12 months postoperatively
and 17 patients were available for 24 months follow-up
(mean 16.5 ± 5.8 month) . There were 27 female and 18
male patients with a mean age of 43.7 ± 7.1 years (range:
28–65 years). Seven patients were treated at C4/5, 27 pa-
tients at C5/6 and 11 patients at C6/7. All patients
showed radiculopathic disorders, 4 of them in combin-
ation with mild signs of myelopathy.
Device design
The ROTAIO Cervical Disc Prosthesis (Fig. 1) is
intended to be used for disc replacement in the cervical
spine (C3-C7). In addition to restoring disc height, its
primary function is to maintain physiological movement
in the affected segment. The ROTAIO Cervical Disc
Prosthesis represents a new unconstrained implant with
a variable centre of rotation which should enable physio-
logical facet-guided movement. For maximum coverage
of the vertebral body end plates a total of 16 different
sizes are available with various surface areas and heights.
The prosthesis is pre-mounted on an insertion bracket
to avoid the need for intraoperative assembly. Instru-
ments specially developed for use with the implant sys-
tem are available to ensure safe application.
The prosthesis consists of a superior and an inferior
end plate (Titanium alloy to ISO 5832-3) on which the
sliding elements (Cobalt-chrome alloy to ISO 5832-12)
are anchored and secured by means of a fixation pin.
The implant design provides an optimum fit to the anat-
omy of the intervertebral space. Assembly of ROTAIO is
done in an axial direction. This has the effect that the
slide plate is radially surrounded by the cover plate,
which prevents the sliding plate from dislodgement. For
optimum primary stabilization the end plates have a
toothed surface. A special blasting treatment of the end
plates increases surface area and thus bony integration.
Surgical technique
A standard right-sided anterior approach was routinely
performed. The surgical technique was similar to those
for a routine anterior cervical decompression. Implant-
ation of the prosthesis was performed strictly following
the manufacturer’s specifications and users´ manual.
The endplate preparation was - corresponding to the de-
sign of the implant - performed using a high-speed drill
followed by curetting the endplates with the manufacture´
s trial-implant. The posterior longitudinal ligaments were
completely removed in all cases. Any remaining superior
posterior osteophytes overhanging the endplate were re-
moved. All cases were treated by neurosurgical specialists
who attended manufacture´s instruction lectures.
Clinical outcome
Clinical evaluations were performed using standardized
questionnaires preoperatively, postoperatively before dis-
charge, 3 to 6, 12 and 24 months after implantation. For
the clinical outcome validated self-assessment outcome
measures including neck disability index (NDI), patient
Fig. 1 ROTAIO Cervical Disc Prosthesis (Source: SIGNUS Medizintechnik
GmbH)
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satisfaction index (PSI), visual analogue scale (VAS) for
neck and arm pain and patients overall satisfaction were
recorded. Additionally the use of non-steroidal anti-
inflammatory drugs (NSAID) was assessed. The NDI
ranged from 0 to 50 and VAS scores from 0 to 10. Con-
cerning PSI patients had to answer the question, “Would
you like to have the same treatment for the same ail-
ment again?” with (1) definitely yes, (2) probably yes, (3)
probably not or (4) definitely not. The use of NSAIDs
was defined as: (1) never, (2) seldom; 1 to 3 times a week,
(3) often; 3 to 5 times a week or (4) always; 1 or more
times a day. The preoperative scores were compared
with the follow-up scores. To analyse overall satisfaction,
the patient had to rate their improvement in (1) excel-
lent, (2) significantly better, (3) good, (4) mild, (5) no im-
provement or (6) worsening of ailment. Complications
were intended to be recorded during surgery and at final
follow-up.
Radiographic outcome
Radiographic imaging observed the prosthesis position
and function, possible signs of fusion or adjacent seg-
ment degeneration in neutral lateral and dynamic flexion
and extension X-rays. To evaluate angular range of mo-
tion within the treated functional unit the Cobb-
technique on dynamic lateral radiographs was used. For
each measurement the mean of two observers were cal-
culated and recorded for analysis. In four patients (index
level C6/7) radiographic assessment was not possible be-
cause of prominent shoulders obscuring the images. All
measurements were performed on source-digitalized im-
ages using IMPAX EE imaging software (AGFA Health-
Care N.V., Belgium).
Statistical analysis
Statistical analyses were performed using IBM SPSS Sta-
tistics Version 20. The trial was designed to detect an
absolute difference between pre- and postoperative data
of one standard deviation with a power of 80 % at a two
sided significance level (probability (p)-value) of 0.05
and a maximal dropout rate of 20 %. Comparisons were
performed with the use of an unpaired t-test, or in case
of nonparametric values with a Mann-Whitney-U test.
Because data analysis did not show a statistically signifi-
cant difference (p > 0.05) between the 12 months and
the 24 months follow-up the results are presented com-




At every time point postoperatively the patients were
significantly improved from their preoperative NDI-
scores (Table 1). The mean NDI had improved from
21.6 ± 9.8 preoperatively to 10.6 ± 8.3 at 3 to 6 months
postoperative (p < 0.001) and to 10.5 ± 9.3 (p < 0.001) at
last follow-up, with an average improvement rate of
51.5 %. A significant reduction of NDI scores was
reached within 4 to 6 weeks after treatment and reached
a plateau by 3 to 6 month after surgery.
Neck pain
Significant improvement of the neck pain score occurred
early postoperatively to 6 months postoperatively and
was maintained at last follow-up (Table 1). The mean
preoperative score for neck pain was 5.3 ± 2.8, decreased
to 2.4 ± 1.8 (p < 0.001) at the 3 to 6 month visit and was
as well improved to 3.3 ± 2.7 (p < 0.001) at last follow-
up. A worsening of neck pain during follow up was ob-
served only in one patient (2.2 %).
Arm pain
The mean VAS score for arm pain improved significantly
from 5.9 ± 3.1 preoperatively to 1.9 ± 1.8 (p < 0.001) at 3 to
6 months postoperatively and to 2.8 ± 2.7 at the last
follow-up (p < 0.001) (Table 1).
Table 1 Clinical Results
Preoperative 3 to 6 month Last follow-up
NDI (range 0-50) 21.65 ± 9.84 10.65 ± 8.32 (p < 0.001) 10.50 ± 9.35 (p < 0.001)
VAS neck pain (range 0-10) 5.30 ± 2.81 2.49 ± 1.86 (p < 0.001) 3.33 ± 2.75 (p < 0.001)
VAS arm pain (range 0-10) 5.93 ± 3.174 1.91 ± 1.81 (p < 0.001) 2.88 ± 2.72 (p < 0.001)
NSAID –use (% of patients)
Never 18.5 % 48.9 % 45.8 %
Seldom 14.8 % 23.3 % 33.3 %
Often 14.8 % 16.3 % 8.3 %
Always 51.9 % 9.3 % 12.5 %
(p < 0.001) (p < 0.001)
NOTE. NDI and VAS are provided as mean ± standard. NSAID-use is provided as percentage of patients
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Used NSAIDs
Concerning the use of NSAIDs, preoperatively 51.9 % of
the patients “always”, 14.8 % “often”, 14.8 % “seldom”
and 18.5 % “never” used painkillers (Table 1). At the 3 to
6 months follow up 48.9 % of the patients “never”,
23.3 % “seldom”, 16.3 % “often” and 9.3 % “always” used
NSAIDs (p < 0.001). At the last follow-up a significant
reduction was observed as well. 45.8 % of the patients
rated their use of painkillers with “never”, 33.3 % with
“seldom”, 8.3 % with “often” and 12.5 % with “always”
(p < 0.001).
Overall success
The analyses of patient overall satisfaction (Table 2) at
last follow-up showed good to excellent results in 95.7 %
of the cases. In detail: 34.8 % showed excellent improve-
ment. 43.5 % of the patients quoted the postoperative re-
sult as significantly better, 19.5 % rated their physical
condition as good. 2.2 % (one patient) described no im-
provement of his ailments. No patient showed a worsen-
ing at last follow up. Concerning PSI at 3 to 6 months
follow-up 65.9 % of the patients answered the question,
“Would you like to have the same treatment for the
same ailment again?” with “definitely yes” and 31.7 % of
the patients with “probably yes”. One patient (2.2 %) an-
swered the question with “probably not”.
Radiographic evaluation
Forty-one patients could be enrolled to radiological
follow-up measurements (Fig. 2). There were no signs of
anterior migration or dislocation of the prosthesis. Sub-
sidence was defined as a decrease of more than 2 mm in
functional spinal unit (FSU) from 3 months to last
follow-up and was observed in no patient. The sagittal
alignment was well restored in all cases. In one case
(2.2 %) the radiographical one-year follow-up showed a
bridging bone ventrally to the prosthesis and mild signs
of adjacent segment disease like new anterior osteo-
phytes (Fig. 3). Overall the analyses of dynamic flexion
and extension X-rays showed no malfunction of the
prosthesis. Concerning the ROM a significantly in-
creased motion was detected at every time point. The
mean cervical spine motion in flexion-extension at the
index level improved from 6.3° ± 2.9° preoperatively to
8.4° ± 2.5° at 3 to 6 month after surgery (p < 0.001) and
to 8.6° ± 2.8° at last follow-up (p < 0.001).
Complications
Self-limiting dysphagia was detected in three patients,
which was probably due to traction or laryngeal nerve ir-
ritation during surgery. There was no other minor or
major complication and no implant-related complication
such as subsidence or fractured vertebrae.
Secondary procedures
In one male patient revision surgery at the index level
was required (2.2 %). Caused by implantation of an
undersized and too ventrally positioned prosthesis the
patient suffered from increasing neck pain (Fig. 4). A
few weeks after the 12 months follow-up the prosthesis
was removed and the patient was treated with ACDF.
Discussion
ACDF is a successful treatment and has shown high pa-
tient satisfaction rates for years. During the last two de-
cades the effectiveness of CDR in treating cervical
degenerative disc diseases has been analysed and in sum-
mary CDR after anterior neurological decompression
may be deemed as an alternative to fusion in selected
patients [5, 8–11]. Till now biomechanics, clinical and
radiological effectiveness of most current available artifi-
cial discs prosthesis have been studied [1, 4, 5, 12–14].
As a newly established device the ROTAIO cervical disc
prosthesis has only been in use for a few years. This is
the first prospective study that analyses its clinical and
radiographic reliability.
The results of this study demonstrated promising clin-
ical and radiological outcomes. Concerning the NDI the
observation showed a significant improvement of 51.5 %
(p < 0.001) after implantation which correlates with
Table 2 Overall Satisfaction and PSI
Before discharge 3 to 6 month Last follow-up
Overall Satisfaction
Excellent Improvement 9.5 % 23.8 % 34.8 %
Significantly better 71.4 % 64.3 % 43.5 %
Good Condition 19.0 % 11.9 % 19.5 %
No Improvement – – –
Worsening – – 2.2 %
PSI
“Would you have the same treatment for the
same ailment again?”
80 % “definitely yes”20 %
“probably yes”
65.9 % “definitely yes”31.9 % “probably
yes”2.2 % “probably not”
77.3 % “definitely yes”22.7 %
“probably yes”
NOTE. All values are presented as percentage of patients
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present studies of other available cervical disc prosthesis
[4–6]. Analysis of VAS showed a significant reduction of
neck and arm pain early after surgery which might pri-
marily be related to sufficient decompression during sur-
gery and the in-hospital pain management. At last
follow-up the improvement of arm and neck pain was
significant as well and was also confirmed by a signifi-
cant reduction of used NSAIDs. Regarding overall satis-
faction 95.7 % of the patients achieved good to excellent
improvement which is in-line with reports that observed
the early results of other established cervical disc pros-
theses and also ACDFs [1, 3, 5, 8, 9, 11, 15–18]. High
patient satisfaction rates were also reinforced by evaluat-
ing the PSI which has shown that 77.3 % of the patients
would definitely have liked to have the same treatment
for the same ailment again at the last follow up.
According to prior clinical trials of cervical arthro-
plasty subsequent secondary surgical intervention was
defined as any revision, removal, reoperation or sup-
plemental fixation [1, 4–6]. Until the last follow-up
in one case (2.2 %) an increase of neck and arm pain
was observed and subsequent secondary surgical
intervention was required to remove a probably
undersized prosthesis. As published by Sasso et al
[1], Burkus et al [7] and Anderson and Hashimoto
[19] for other disc prostheses the results of this
study show a very low rate of secondary procedures
and no prostheses related complications during or
after surgery. According to Li et al [6] proper selec-
tion of patients, exact intraoperative strategy and ad-
equate neural decompression is required to achieve
satisfactory clinical outcomes.
Fig. 2 Flexion (a), neutral (b) and extension (c) x-ray showing the successful operation – especially the variable mechanical centre of rotation (CR)
of the device moving forward and backward (white arrows) - of a ROTAIO cervical disc prosthesis at the level C6-C7 in a 52 years old female
patient, 6 month after implantation
Fig. 3 Flexion (a), neutral (b) and extension (c) x-ray showing an immobilized ROTAIO cervical disc prosthesis due to heterotopic ossification at
the level C6-C7 in a 48 years old female patient, 12 month after implantation
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Radiographic analysis showed no dislocation, anterior
migration or malfunction of the prosthesis. As reported
by Heller et al ROM values measured radiographically
can be influenced by the radiographic technique itself,
patient´s motivation or other – unknown – factors [5].
Nevertheless most authors observed motion preserva-
tion at the implanted level and characterized it as one of
the fundamental benefits of CDR [1, 3, 4, 16, 20]. In the
present study the prosthesis maintained physiological
segmental motion with a mean flexion-extension differ-
ence of 8.4° in the 3 to 6 month visit and 8.6° at the last
follow-up. According to Heller et al [4] an increasing
ROM probably is a sign of less pain and higher patient´s
motivation. Additionally a restored lordotic sagittal
alignment was observed in all cases thus compared to
other available CDR devices the ROTAIO prosthesis
does not show a lordotic design like e.g. the Discover
disc [6]. A fact that might be an advantage over pros-
theses like the Bryan disc, for which segmental kyphosis
of the index level – persisting for more than 6 months
postoperatively - was reported by Pickett et al [20]. The
radiographic analysis also showed a low rate (2.2 %) of
spontaneous fusion as measured by presence of bridging
bone. This result may be a consequence of the preserved
ROM but according to the works of Heller et al [5] it
could also be influenced by patient selection. The au-
thors describe that patients with significant spondylosis
may have a greater likelihood of spontaneous fusion [5].
Adjacent segment disease (ASD) following uninstru-
mented ACDF has been reported to occur in 25 % of pa-
tients within 10 years and shows an incidence of 2.9 %
per year [21, 22]. Based on the rationale that CDR helps
to preserve the biomechanics of the spine in the index
level and in addition also in the adjacent segments the
potential for decreasing ASD was one of the most strik-
ing arguments for total disc arthroplasty. As reported by
Riew et al [22] it is quite challenging to compare rates of
radiographic or symptomatic ASD across the available
literature because authors use substantially different
definitions for their analysis and because there is no dir-
ect relationship between radiographic and symptomatic
ASD. In the present study radiographic ASD was defined
as new anterior osteophyte formation or enlargement of
existing osteophytes and the rate of reoperation at the
level directly adjacent to the treated level. In one case
(2.2 %) anterior bridging bone at the index level and
new osteophyte formations in the adjacent cranial level
was observed. The low rate of ASD goes in line with the
results of other authors and may be artificially low be-
cause of the definition as mentioned above and the fol-
low up with a maximum period of just 24 month [1, 7,
22, 23] thus e.g. Park et al [24] reported that adjacent-
level anterior disc space ossification (ALOD) occurs
within the first 12 months after treatment and that pa-
tients with no ossification at 24 months are very unlikely
to progress to advanced ossification. Furthermore - ac-
cording to the work of Nunley et al [25] – over and
above the device design there may be lots of different
factors influencing the development of an ASD like e.g.
age, sex, smoking habit or coexisting diseases.
Concerning the development of symptomatic ASD the
results of this study show a mild increase of the mean
VAS regarding neck pain from the 6 months visit to the
last follow up ( 2.42 to 3.33; p > 0.05). Nevertheless this
may be associated to the prosthesis or may be a part of
degenerative spine´s natural history, long-term follow-
up is necessary to evaluate if differences in adjacent seg-
ment motion and radiographical degeneration will affect
the development of clinical ASD. To what extent the
new design of the ROTAIO cervical disc prosthesis is
able to reduce the risk of ASD and how far the device
could protect the uncovertebral and facet joints from
overload must be the aim of upcoming biomechanical
analysis.
Overall new technology such as artificial disc devices
requires long-term follow up to assess durability, the
biologic compatibility and the response of the prosthesis
to its environment. Typically failure of other joint
arthroplasty does not occur before five to ten years after
surgery. Therefore spinal disc prostheses similarly need
to be assessed repetitively and for a longer period [1,
18]. Nevertheless based on clinical outcome according
to the significant reduction of NDI and VAS scores,
the high overall satisfaction and the evaluated safety
of the device the ROTAIO prosthesis may be deemed
as a good alternative for currently available cervical
disc prostheses.
Fig. 4 X-ray in neutral position (a: lateral view; b: anterior view)
showing an undersized and too ventrally positioned ROTAIO cervical
disc prosthesis at the level C5-C6 (white arrows) in a 38 years old
male patient, 3 month after implantation. Within the first 12 month
of follow up the patient suffered from progressive neck pain
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Limitations
There are some limitations in this study including the
small number of patients, the lack of an ACDF control
group and the limited follow up. Moreover the biomech-
anical behaviour of the ROTAIO disc in axial rotation
and lateral bending has not been evaluated. Additionally
the comparison with other kinds of artificial discs may
provide further insights into the characteristics of differ-
ent CDR devices.
Conclusions
The early results of this prospective, observational study
show that cervical disc arthroplasty with the ROTAIO
Cervical Disc Prosthesis seems to be safe and effective
for the treatment of symptomatic single-level degenera-
tive disc disease. Additionally patients had significantly
improved NDI and VAS scores, showed a lower rate of
NSAID-use and an excellent overall success at last
follow-up. Thus, according to recent studies of other
cervical disc prostheses the results confirm and support
the role of total disc replacement as an alternative to
ACDF, studies focusing on clinical long-term outcome
and especially on preserving ASD are warranted.
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